Data on new Novo Nordisk obesity drug disappoints in trial, shares drop
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial
Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...
Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial
Novo Nordisk's REDEFINE 2 trial shows CagriSema led to significant weight loss in patients with obesity and type 2 diabetes. Regulatory filing is planned for 2026.
Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations
Shares of Novo Nordisk’s (NVO) are down over 9% at the time of writing after the company announced the results from its latest weight-loss drug ...
Novo Nordisk reports REDEFINE 2 trial of CagriSema achieved primary endpoint
Novo Nordisk (NVO) announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE program. REDEFINE 2 is a 68-week efficacy ...
NBC Washington6d
Mom with stage 4 cancer approved for clinical trial after NIH funding cuts left her in limbo
A young mom battling stage 4 cancer says she was supposed to start a clinical trial at the National Institutes of Health in just a few weeks — but she was left in limbo after her doctors told ...
Novo Nordisk says trial with next-gen drug in diabetics shows 15.7% weight loss
Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...
Novo Nordisk trial with next-gen diabetes drug shows 15.7% weight loss but shares fall
Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...
Sky4d
Phone waiting times for public services could be cut in half after successful AI trial, minister suggests
But with the government talking of an AI revolution, one trial has used the tech to drastically reduce the volume of minutes spent on hold. Citizens Advice teams in Stockport, Oldham, Rochdale and ...
Diterpene-based drug achieves functional neuronal regeneration after brain injury in preclinical study
Researchers from the University of Seville and the University of Cadiz, coordinated by the professors of Physiology Pedro ...
BioPharma Dive4d
Novo’s Wegovy successor disappoints in second large trial
A study in people with obesity and diabetes again found CagriSema helps people lose weight, but not by enough to clearly ...
pharmaphorum2d
Pfizer pauses DMD gene therapy trial after boy’s death
The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted ... lifted in 2022 after an investigation ...